Description
Letrosis 2.5 Tablet 5’s is a potent medication designed to combat certain types of cancer. Each tablet contains 2.5mg of Letrozole, a selective aromatase inhibitor. This drug is primarily used in postmenopausal women with hormone-receptor-positive breast cancer, specifically for the treatment of early-stage and advanced breast cancer. By inhibiting the aromatase enzyme, Letrosis helps reduce the production of estrogen in the body, thereby slowing or halting the growth of cancer cells. It is essential to follow the prescribed dosage and schedule for optimal results. Consult your healthcare provider for more information on how Letrosis can aid in your cancer care journey.
Reviews
There are no reviews yet.